In 2023, Japan leads the nervous system medicine sales with $9.75 billion, showing a 4.71% annual increase. Australia follows at $1.5 billion with a 2.58% rise. Portugal's market is valued at $1.14 billion, marking a 4.34% growth. Greece and Hungary see declines of 4.07% and 3.25%, with sales at $0.9637 billion and $0.3658 billion, respectively.
Future trends to watch:
- Innovative therapies and personalized medicine could drive growth, especially in developed markets like Japan and Australia.
- Emerging economies may contribute to future sales increases as access to healthcare improves.
- Regulatory changes and healthcare reforms will impact market dynamics.
Top countries in Nervous System Medicine Sales by Country
| # | 5 Countries | Million US Dollars PPP | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Japan | 9,750 | 2023 | +1.17% | +4.71% | View data |
| 2 | 2 Australia | 1,500 | 2023 | +2.5% | +2.58% | View data |
| 3 | 3 Portugal | 1,140 | 2023 | +4.35% | +4.34% | View data |
| 4 | 4 Greece | 963.7 | 2023 | -6.69% | -4.07% | View data |
| 5 | 5 Hungary | 365.8 | 2023 | +9.82% | -3.25% | View data |
